This article is part of the PlexusDx Education Hub science-backed guidance on GLP-1 medications, metabolic health, and precision weight management
Clinically, this is known as telogen effluvium and has been seen in some GLP-1 patients
Associations of semaglutide with Alzheimers disease-related dementias in patients with type 2 diabetes: a real-world target trial emulation study
Bottom Line: What to Know Before Starting With altRx altRx is a self-pay GLP-1 telehealth platform that, according to its own published source materials, operates a clearly disclosed three-entity model: altRx as the technology and marketing platform, independent medical groups as the clinical decision-makers, and partner pharmacies described by altRx as USA-certified as the medication dispensers
This depends on your medication regimen, whether you hold a group 1 or group 2 licence and other individualised factors
The PlexusDx Precision Peptide Genetic Test identifies your unique peptide-pathway variants across 14 biological mechanisms and 49 peptides, revealing which GLP-1 approach may work best for your genetic profile
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
:format(webp))
